Nasopharangeal Cancer

Explore clinical trials studying Nasopharangeal Cancer. Study availability and eligibility vary by location and protocol.

7 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Nasopharangeal Cancer trial results

Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions: Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations: Research Site Birmingham, Alabama, United States

Research Site Bullhead City, Arizona, United States

Research Site Casa Grande, Arizona, United States

Research Site San Diego, California, United States

View all 18 locations

View Trial Details

Recruiting

LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC

NCT07325539

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharangeal Cancer, +13 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Shenzhen, Guangdong, China

View Trial Details

Recruiting

Topical Chlorhexidine Spray for the Prevention of Acute Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma:

NCT07559877

Conditions: Nasopharangeal Cancer
Locations: Jiangxi Cancer Hospital Nanchang, Jiangxi, China

View Trial Details

Recruiting

A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma

NCT07392320

Conditions: Nasopharangeal Cancer
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC

NCT07332247

Conditions: Head and Neck Neoplasms, Nasopharangeal Cancer, Nasopharyngeal Diseases, +9 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC

NCT07235319

Conditions: Distant Metastasis, Nasopharangeal Cancer
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

Hunan Cancer Hospital Changsha, China

Fujian Cancer Hospital Fuzhou, China

Zhejiang Cancer Hospital Hangzhou, China

View Trial Details

Not Yet Recruiting

Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

NCT07238569

Conditions: Nasopharangeal Cancer, Nasopharyngeal Cancinoma (NPC)
Locations: Not specified

View Trial Details

Nasopharangeal Cancer

Nasopharangeal Cancer trial results

DESTINY-PANTUMOUR04

LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC

Topical Chlorhexidine Spray for the Prevention of Acute Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma:

A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma

PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC

PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC

Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

Related conditions